Moderna COVID-19 vaccine trial shows it is safe and effective in teens

Embargoed until: Publicly released: 2021-08-12 07:00

International

Governor Tom Wolf, CC BY 2.0 <https://creativecommons.org/licenses/by/2.0>, via Wikimedia Commons

The Moderna COVID-19 vaccine appears safe in adolescents with only mild side effects reported, according to a phase 2/3 trial of over 3000 teens aged 12 to 17. The study found the immune response in teens was similar to that seen in young adults, and the vaccine effectively prevented COVID-19 infection.

Attachments

Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.

Research Massachusetts Medical Society, Web page Please link to the article in online versions of your report (the URL will go live after the embargo ends).

Journal/
conference: New England Journal of Medicine

Research:Paper

Organisation/s: Moderna

Funder: Funded by Moderna and the Biomedical Advanced Research and Development Authority; Teen COVE ClinicalTrials.gov number, NCT04649151

Media Contact/s

Contact details are only visible to registered journalists.